This bill amends the Code of Iowa to establish definitions and regulations concerning manufacturers and distributors of 340B drugs. It introduces new subsections that define a "340B drug" as a covered outpatient drug sold at a reduced price under federal law, and clarifies the roles of "distributor" and "manufacturer" in relation to these drugs. Specifically, a distributor is defined as any entity, excluding manufacturers, that engages in the wholesale distribution of prescription drugs, while the manufacturer is defined according to federal law.

Additionally, the bill imposes restrictions on manufacturers and distributors, prohibiting them from denying, restricting, or interfering with the acquisition of 340B drugs by covered entities or their delivery to contract pharmacies, except in cases where such actions are prohibited by the U.S. Department of Health and Human Services. This aims to ensure that covered entities can access necessary medications without undue barriers.

Statutes affected:
Introduced: 510D.1, 510D.2